The linkage between bone mineral density and immune system highlights an immunological aspect of osteoporosis. Trabecular bone loss is associated with estrogen deficiency and can be inhibited by addition of IL-17 monoclonal antibody.
Sixty four postmenopausal women were divided into four subgroups according to BMDs and IL-17 levels. Subgroup OL: postmenopausal osteoporotic women with low IL-17 levels (2.85± 0.12 ng/ml), n=6,mean age of 60±6 years,mean lumbar BMD and T-score values: 0.695±0.05 g/cm 2 and -3.2±0.47; Subgroup OH: postmenopausal osteoporotic women with high IL-17 levels (3.79 ±0.55 ng/ml),n=35, mean age of 68±10 years, mean lumbar BMD and T-score values: 0.685±0.07 g/cm 2 and -3.31±0.63. Subgroup PL: postmenopausal osteopenic women with low IL-17 levels (2.9 ±0.12 ng/ml), n=8, mean age of 63±8 years, mean lumbar BMD and T-score values: 0.828±0.04 g/cm 2 and -2.01±0.47; Subgroup PH: postmenopausal osteopenic women with high IL-17 levels (3.48±0.38 ng/ml), n=15, mean age of 62±8 years, mean lumbar BMD and T-score values: 0.83±0.05 g/cm 2 and -1.98±0.47.
The HLA-A, -B, -Cw, -DRB1 and -DQB1 alleles were tested for all individuals with polymerase chain reaction (Biotest HLA PCR SSP kit, Biotest Bio-Rad Medical Diagnostics GmbH, Germany.
The serum IL-17A levels were measured with enzyme-linked immunosorbent assay (ELISA) (PeproTech,USA). The bone density (BMD g/cm 2 ) of lumbar spines (L1-L4) was measured by dual energy X-ray absorptiometry (DXA) using Hologic Discovery Wi.
 The results using Hardy-Weinberg equilibrium (HWE) test, did not show remarkable difference among the subgroups (Table 1) .  The osteoporotic women with high IL-17 (subgroup OH) levels showed increased number of alleles in comparison with those found in subgroup with low IL-17 levels (OL) ( Table 2) .  In women with high IL-17, the allele frequencies of HLA-Cw*01 and -Cw*15, as well as the haplotype frequencies of HLA-A*02-Cw*01 or HLA-A*02-DQB1*06, and HLA-Cw*01-DQB1*06 were significantly increased in osteopenic women compared with osteoporotic ones (Table 3 and 4) .  The pair of loci for HLA-Cw*01-DQB1*06 was not in linkage disequilibrium in subgroup OL (Table 5) .  The genetic distances between subgroups with high IL-17 (subgroups OH and PH) were closer together compared with subgroups with low IL-17 (OL and PL subgroups) (Figure 1 ).
ECE 2013, 27 April -1 May, Copenhagen, Denmark molil@endomed.hu osteoporosis osteopenia osteoporosis osteopenia osteoporosis osteopenia Our results revealed in postmenopausal osteoporosis that the high IL-17 levels, which cytokine is a bone-wasting accelerating factor, showed HLA associations at loci of HLA-A, -C and -DQB1. The absence of HLA-Cw*01 and -Cw*15 alleles, as well as HLA-A*02-Cw*01, -A*02-DQB1*06 and -Cw*01-DQB1*06 haplotypes was connected to high IL-17 levels. The HLA-allele association showed shorter genetic distances between subgroups with high IL-17 than between osteoporotic and osteopenic subgroups with low IL-17. In postmenopausal osteoporosis, the presence of HLA-Cw*01 and -Cw*15 alleles, as well as of HLA-A*02-Cw*01, -A*02-DQB1*06 and -Cw*01-DQB1*06 haplotypes demonstrated preventive role in the increase of IL-17.
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